OR WAIT null SECS
May 28, 2015
Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or biopolar I disorder.
May 27, 2015
Pharmaceutical companies are constantly aiming for shorter drug-development cycles and advances in formulation development produce significant benefits.
This new pharmaceutical stability storage facility will enable the company to expand its analytical and formulation offerings to the pharmaceutical and biotech industries.
May 20, 2015
The new guideline replaces the previous version-CHMP/EWP/240/95 Revision 1.
May 04, 2015
Advances in transdermal drug delivery, particularly with microneedles, are enabling a wider range of drugs to be delivered through the skin.
May 02, 2015
An integrated pilot plant tests heteronucleation and continuous crystallization.
April 13, 2015
The license approval marks another milestone in Aptar Pharma’s ongoing service development to provide large-scale production services to customers.
April 10, 2015
As the prevalence of falsified medicines continues to increase, Switzerland is taking measures to secure its supply chain such as the implementation of serialization.
Aptar Pharma has partnered with Shanghai Sine Promod Pharmaceutical to develop and launch its new budesonide dry powder inhaler (DPI), which features Aptar Pharma’s user-friendly and cost-effective Twister DPI.
April 02, 2015
Emerging controlled-release technologies could lead to more effective therapies in the near future.